Amicus Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03152W1099
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityFOLD / Amicus Therapeutics, Inc.
InstitutionGuggenheim Capital Llc
Latest Disclosed Ownership84,973 shares
Latest Disclosed Value $ 1,228,710
Guggenheim Capital Llc reports 4.72% decrease in ownership of FOLD / Amicus Therapeutics, Inc.

On May 15, 2026 - Guggenheim Capital Llc filed a 13F-HR form disclosing ownership of 84,973 shares of Amicus Therapeutics, Inc. (US:FOLD) valued at $1,228,710 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 89,180 shares of Amicus Therapeutics, Inc.. This represents a change in shares of -4.72% during the quarter. The current value of the position is $1,231,259 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AMICUS THERAPEUTIC COM 03152W109 84,973 -4,207 -4.72 1,229 -3.23 0.0047
2026-02-17 2025-12-31 13F AMICUS THERAPEUTICS COM 03152W109 89,180 2,572 2.97 1,270 86.07 0.0045
2025-11-13 2025-09-30 13F AMICUS THERAPEUTICS COM 03152W109 86,608 -13,882 -13.81 682 18.61 0.0035
2025-08-13 2025-06-30 13F AMICUS THERAPEUTICS COM 03152W109 100,490 15,353 18.03 576 -17.15 0.0046
2025-05-14 2025-03-31 13F AMICUS THERAPEUTICS COM 03152W109 85,137 3,370 4.12 695 -9.87 0.0064
2025-02-13 2024-12-31 13F AMICUS THERAPEUTICS COM 03152W109 81,767 -13,210 -13.91 770 -24.06 0.0062
2024-11-13 2024-09-30 13F AMICUS THERAPEUTICS COM 03152W109 94,977 -1,138 -1.18 1,014 6.40 0.0071
2024-08-14 2024-06-30 13F AMICUS THERAPEUTICS COM 03152W109 96,115 -2,290 -2.33 953 -17.77 0.0068
2024-05-14 2024-03-31 13F AMICUS THERAPEUTICS COM 03152W109 98,405 3,043 3.19 1,159 -14.34 0.0082
2024-02-14 2023-12-31 13F AMICUS THERAPEUTICS COM 03152W109 95,362 -5,241 -5.21 1,353 10.63 0.0102
2023-11-14 2023-09-30 13F AMICUS THERAPEUTICS COM 03152W109 100,603 -2,520 -2.44 1,223 -5.56 0.0105
2023-08-11 2023-06-30 13F AMICUS THERAPEUTICS COM 03152W109 103,123 -2,971 -2.80 1,295 10.12 0.0102
2023-05-11 2023-03-31 13F AMICUS THERAPEUTICS COM 03152W109 106,094 106,094 1,177 0.0099
2022-11-14 2022-09-30 13F AMICUS THERAPEUTICS COM 03152W109 0 -32,199 -100.00 0 -100.00
2022-08-15 2022-06-30 13F AMICUS THERAPEUTICS COM 03152W109 32,199 -7,549 -18.99 346 -8.22 0.0027
2022-05-16 2022-03-31 13F AMICUS THERAPEUTICS COM 03152W109 39,748 2,993 8.14 377 -11.29 0.0023
2022-02-14 2021-12-31 13F AMICUS THERAPEUTICS COM 03152W109 36,755 -130,987 -78.09 425 -73.47 0.0022
2021-11-15 2021-09-30 13F AMICUS THERAPEUTICS COM 03152W109 167,742 -14,183 -7.80 1,602 -8.61 0.0096
2021-08-13 2021-06-30 13F AMICUS THERAPEUTICS COM 03152W109 181,925 -4,635 -2.48 1,753 -4.93 0.0103
2021-05-13 2021-03-31 13F AMICUS THERAPEUTICS COM 03152W109 186,560 45,862 32.60 1,844 -43.23 0.0121
2021-02-16 2020-12-31 13F AMICUS THERAPEUTICS COM 03152W109 140,698 119,126 552.23 3,248 964.92 0.0204
2020-11-13 2020-09-30 13F AMICUS THERAPEUTICS COM 03152W109 21,572 21,572 305 0.0022
2019-08-14 2019-06-30 13F AMICUS THERAPEUTICS COM 03152W109 0 -52,777 -100.00 0 -100.00
2019-05-15 2019-03-31 13F AMICUS THERAPEUTICS COM 03152W109 52,777 -1,777 -3.26 718 37.55 0.0059
2019-02-14 2018-12-31 13F AMICUS THERAPEUTICS COM 03152W109 54,554 -223,720 -80.40 522 -84.48 0.0044
2018-11-14 2018-09-30 13F AMICUS THERAPEUTICS COM 03152W109 278,274 17,816 6.84 3,364 -17.31 0.0219
2018-08-14 2018-06-30 13F AMICUS THERAPEUTICS COM 03152W109 260,458 33,105 14.56 4,068 18.98 0.0272
2018-05-15 2018-03-31 13F AMICUS THERAPEUTICS COM 03152W109 227,353 17,470 8.32 3,419 13.17 0.0083
2018-02-14 2017-12-31 13F AMICUS THERAPEUTICS COM 03152W109 209,883 -60,025 -22.24 3,021 -25.76 0.0072
2017-11-14 2017-09-30 13F AMICUS THERAPEUTICS COM 03152W109 269,908 16,133 6.36 4,069 59.26 0.0096
2017-08-14 2017-06-30 13F AMICUS THERAPEUTICS COM 03152W109 253,775 -32,138 -11.24 2,555 25.31 0.0068
2017-05-15 2017-03-31 13F AMICUS THERAPEUTICS COM 03152W109 285,913 -20,292 -6.63 2,039 33.97 0.0055
2017-02-14 2016-12-31 13F AMICUS THERAPEUTICS COM 03152W109 306,205 306,205 0.00 1,522 0.0044
2016-08-15 2016-06-30 13F AMICUS THERAPEUTICS COM 03152W109 0 -299,607 -100.00 0 -100.00
2016-05-16 2016-03-31 13F AMICUS THERAPEUTICS COM 03152W109 299,607 8,739 3.00 2,532 -10.24 0.0080
2016-02-16 2015-12-31 13F AMICUS THERAPEUTICS COM 03152W109 290,868 138,233 90.56 2,821 32.13 0.0082
2015-11-16 2015-09-30 13F AMICUS THERAPEUTICS COM 03152W109 152,635 152,635 0.00 2,135 0.0066
2015-05-15 2015-03-31 13F AMICUS THERAPEUTICS COM 03152W109 0 -10,054 -100.00 0 -100.00
2015-02-17 2014-12-31 13F AMICUS THERAPEUTICS COM 03152W109 10,054 10,054 0.00 84 0.0002
2014-11-14 2014-09-30 13F AMICUS THERAPEUTICS COM 03152W109 0 -16,717 -100.00 0 -100.00
2014-08-14 2014-06-30 13F AMICUS THERAPEUTICS COM 03152W109 16,717 -7,370 -30.60 56 14.29 0.0001
2014-05-16 2014-03-31 13F AMICUS THERAPEUTICS COM 03152W109 24,087 3,823 18.87 49 4.26 0.0001
2014-02-14 2013-12-31 13F AMICUS THERAPEUTICS COM 03152W109 20,264 2,233 12.38 47 14.63 0.0001
2013-11-14 2013-09-30 13F AMICUS THERAPEUTICS COM 03152W109 18,031 4,285 31.17 41 28.13 0.0001
2013-08-22 2013-06-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 13,746 13,746 32 0.0001
2013-08-14 2013-06-30 13F AMICUS THERAPEUTICS COM 03152W109 13,746 32 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.